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Abstract
Objective: Both aerobic (AER) and resistance (RES) training, if maintained over a period of several months, reduce HbA1c
levels in type 2 diabetes subjects. However, it is still unknown whether the short-term effects of these types of exercise on
blood glucose are similar. Our objective was to assess whether there may be a difference in acute blood glucose changes
after a single bout of AER or RES exercise.
Study Design: Twenty-five patients participating in the RAED2 Study, a RCT comparing AER and RES training in diabetic
subjects, were submitted to continuous glucose monitoring during a 60-min exercise session and over the following 47 h.
These measurements were performed after 10.9+0.4 weeks of training. Glucose concentration areas under the curve (AUC)
during exercise, the subsequent night, and the 24-h period following exercise, as well as the corresponding periods of the
non-exercise day, were assessed. Moreover, the low (LBGI) and high (HBGI) blood glucose indices, which summarize the
duration and extent of hypoglycaemia or hyperglycaemia, respectively, were measured.
Results: AER and RES training similarly reduced HbA1c. Forty-eight hour glucose AUC was similar in both groups. However,
a comparison of glucose AUC during the 60-min exercise period and the corresponding period of the non-exercise day
showed that glucose levels were lower during exercise in the AER but not in the RES group (time-by-group interaction
p= 0.04). Similar differences were observed in the nocturnal periods (time-by-group interaction p= 0.02). Accordingly,
nocturnal LBGI was higher in the exercise day than in the non-exercise day in the AER (p = 0.012) but not in the RES group
(p = 0.62).
Conclusions: Although AER and RES training have similar long-term metabolic effects in diabetic subjects, the acute effects
of single bouts of these exercise types differ, with a potential increase in late-onset hypoglycaemia risk after AER exercise.
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Introduction
Current guidelines for exercise in subjects with type 2 diabetes
recommend performing, whenever possible, both aerobic and
resistance exercise training [1]. Interestingly, some recent com-
parative studies showed that these exercise modalities, if main-
tained over a period of several months, are similarly effective in
reducing HbA1c levels in diabetic patients [2–4]. However, it is
unknown whether the acute blood glucose changes induced by
each single session of aerobic or resistance exercise are also similar.
As a consequence, it is still unclear whether medication dosage
and/or dietary carbohydrate adjustments to exercise should differ
according to the scheduled type of physical activity.
A single bout of exercise increases skeletal muscle glucose
uptake. Nevertheless, plasma glucose is normally maintained
constant by increased hepatic glucose production and mobilization
of alternate fuels [5]. In subjects with type 2 diabetes performing
moderate aerobic physical activity, glucose uptake generally rises
more than hepatic glucose production, and therefore blood
glucose tends to fall [6]. Muscle glucose uptake remains high in
PLOS ONE | www.plosone.org 1 December 2012 | Volume 7 | Issue 12 | e49937
the post-exercise period, with the contraction-mediated pathway
persisting for several hours and insulin-mediated uptake for longer
[7]. This phenomenon is usually beneficial in these patients and, in
the absence of pharmacological interference, concurrent reduction
of insulin levels avoids the risk of hypoglycaemia. However, the
synergistic effects of exercise and antidiabetic medications may
provoke a more pronounced reduction of glucose concentrations
[8]. This interaction may still be helpful in improving the
metabolic control. Nevertheless, it increases the risk of hypogly-
caemia, which may occur either during or several hours after the
exercise.
In clinical practice, assessment of short-term changes in glucose
concentrations is primarily based on self-monitoring of blood
glucose. However, most hypoglycaemic episodes may be missed
[9–10], particularly during the night. A recently introduced tool to
assess blood glucose changes, available during exercise and free-
living, is the continuous glucose monitoring system (CGMS),
which can record blood glucose concentrations for several days.
In the present study, using CGMS, we have compared the
effects on blood glucose of a single bout of aerobic exercise or
resistance exercise in a group of type 2 diabetic patients included
in a regular training programme. Our hypothesis is that aerobic
exercise and resistance exercise, despite similar effects on long-
term metabolic control in these subjects, may differently affect
glucose concentrations during and for several hours after the
exercise.
Materials and Methods
Ethics statement
The study was approved by the Ethical Committee of the
Azienda Ospedaliera Universitaria Integrata of Verona, Italy, and
written informed consent was obtained from all participants. All
investigations were conducted according to the principles
expressed in the Declaration of Helsinki.
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Design
This is a sub-project of the RAED2 study, a randomized
controlled trial aimed at comparing the metabolic effects of
aerobic and resistance training in type 2 diabetes subjects. In this
trial, 60-min exercise sessions were scheduled 3 times weekly, on
alternate days, for 4 months.
In this sub-project, blood glucose was continuously monitored
by CGMS over 48-h, starting with an exercise session.
To adequately assess the effects of the two exercise modalities,
the CGMS sensor was implanted in all subjects after at least two
months of training, i.e. when scheduled exercise volumes had been
reached and maintained for several weeks.
Subjects
Inclusion and exclusion criteria of the study, sample size
calculation and randomization schedule have been reported in
detail elsewhere [4]. The only allowed diabetes medications were
oral hypoglycaemic agents. Of the 40 eligible patients enrolled in
the RAED2 study, 38 completed the trial and 26 of them agreed to
participate in this sub-project and had the CGMS implanted. In
one of these subjects the CGMS failed to record the data.
Therefore, glucose measurements were collected in 25 subjects, 13
from the aerobic and 12 from the resistance group (Fig. 1).
Training protocols
The aerobic group exercised 3 times a week on different
cardiovascular equipment (treadmill, cyclette and elliptical).
During the initial phase (weeks 1–2), participants exercised for
30–40 min at 40–60% of the reserve heart rate. Thereafter,
training duration gradually increased up to 60 min per session
and, subsequently, intensity gradually reached 60–65% of the
reserve heart rate. The target training intensity was achieved after
5 weeks in all subjects of the AER group. Heart rate monitors
(Polar S810i; Polar Electro, Kempele, Finland) were used to
standardize exercise intensity.
The resistance group performed 9 different exercises in 3 weekly
sessions, by using weight machines and free weights. During the
learning phase (weeks 1–2) subjects performed 3 series of 10–12
repetitions at 30–50% 1RM. Subsequently, the amount of weight
lifted increased progressively. All participants were asked to
perform each repetition in a slow, controlled manner, with a rest
of 60 s between sets. The training workload was increased after
subjects had successfully achieved 12 repetitions with an appro-
priate technique. The target intensity of the training programme
(10–12 repetitions at 70–80%1RM) was reached after 6 weeks in
all subjects of the RES group.
All training sessions were supervised by exercise specialists. In
this sub-project, the exercise sessions started for all subjects at 6:30
p.m.
Continuous glucose monitoring system
The CGMS measures interstitial glucose concentrations via the
glucose oxidase reaction, with the enzyme immobilized on a
subcutaneously inserted electrode. The CGMS used was the
Guardian REAL-Time (Medtronic Minimed, Inc., Northridge,
CA, USA), which consists of a sensor-transmitter implanted into
the abdominal subcutaneous tissue and a reader-monitor with
wireless radio frequency sensor. This system was previously
validated [11].
For this protocol, the patient checked into to the Diabetes Clinic
of Verona Hospital in the morning, after a 12-h overnight fast.
The CGMS was inserted at 8:30–9:30 am by an experienced
physician, following the manufacturer’s instructions. The sensor’s
display and the patient’s watch were both synchronized with the
clinical trial unit clock. Self-measured blood glucose was used to
calibrate the instrument and the first calibration was performed
2 h after initialization. If no abnormalities were observed, the
patients were subsequently discharged. Thereafter, the patients
were asked to maintain their normal daily activities and diet.
During registration, the participants self-measured blood glucose
at least four times per day and values were used to calibrate the
CGMS, as required by the device. However, subjects were blinded
to CGMS measurements. After about 60 h the sensors were
removed and the data collected.
CGMS data
We analysed glucose concentration data recorded in a 48-h
period, starting at 6:30 pm on the day in which the CGMS sensor
was implanted, corresponding to the beginning of a 60-min
exercise session.
Analyses were carried out over the entire 48-h period and in
several selected time periods. These comprised the 6:30–7:30 pm
exercise period, the subsequent nocturnal period, and the 24-h
period following the beginning of the exercise session (exercise
day), as well as the corresponding time periods of the following
(non-exercise) day. The nocturnal period was defined as the time
period in which all subjects included in the study were asleep,
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corresponding to the interval 1:00–5:00 am. An overview of the
study is provided in Figure 2.
Hypoglycaemias were classified following the ADA Workshop
on Hypoglycaemia definitions (severe hypoglycaemia, documented
symptomatic hypoglycaemia, or asymptomatic hypoglycaemia)
[12]. In particular, we defined an asymptomatic hypoglycaemia as
an event not accompanied by typical symptoms of hypoglycaemia
but with a measured plasma glucose concentration #70 mg/dl;
symptomatic hypoglycaemia as an event during which typical
symptoms of hypoglycaemia are accompanied by a measured
plasma glucose concentration #70 mg/dl, and severe hypogly-
caemia as an event requiring assistance of another person to
actively administer carbohydrate, glucagons, or other resuscitative
actions.
The low blood glucose index (LBGI) and the high blood glucose
index (HBGI) were calculated by using the formulas proposed by
Kovatchev et al, as adapted for the frequently sampled CGMS
output [13]. These indices summarize in a single number the
percentage of low (,70 mg/dL) or high (.180 mg/dL) glucose
readings, respectively, and their magnitude. LBGI provides a
reliable assessment of severe hypoglycaemia risk [14].
Other measurements
Weight was recorded on an electronic scale (Tanita BWB-800,
MA, USA), height was measured with a Harpenden stadiometer
(Holtain Ltd., Crymych Pembs, UK), and BMI was calculated as
weight (kg)/height2 (m).
HbA1c was measured by a Diabetes Control and Complications
Trial (DCCT)-aligned method, with an automated high perfor-
mance liquid chromatography analyzer (Bio-Rad Diamat, Milan,
Italy).
VO2peak was measured during a cycle ergometer incremental
stress test by breath-by-breath analysis of oxygen consumption and
carbon dioxide production. After a warm-up load of 30 W for
3 min, 10-W increments were applied each minute up to
voluntary exhaustion.
Diet
All participants in the RAED2 study received preliminary
healthy dietary instructions, as previously described [4]. Moreover,
subjects included in this sub-project were asked to maintain their
diet and medications stable over the 48-h study period. The food
Figure 1. Study flow diagram.
doi:10.1371/journal.pone.0049937.g001
Figure 2. Schematic overview of the study design. The CGMS sensor was inserted at 8:30–9:30 am. Glucose concentrations were recorded over
a 48-h period, starting at 6:30 pm of the same day, corresponding to the beginning of the 60-min exercise session. Several time periods were
separately analyzed: the exercise period (6:30–7:30 pm), the subsequent nocturnal period (1:00 am–5:00 am) and the 24-h period following the
beginning of the exercise session (exercise day), as well as the corresponding time periods of the following (non-exercise) day. The CGMS was
removed at 7:30–8:30 pm of the non-exercise day. Meal times were between 6:30–8:30 am for breakfast, 12:30 am to 2:00 pm for lunch, 3:30–4:30 pm
for a snack and 8:00–9:30 pm for dinner.
doi:10.1371/journal.pone.0049937.g002
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intake was divided into breakfast, lunch, dinner and a snack. Meal
times were between 5:30–8:30 am for breakfast, 12:30 pm to 2:00
pm for lunch, 3:30–4:30 pm for a snack and 8:00–9:30 pm for
dinner, and remained constant for each subject in the exercise and
non-exercise day. Subjects were also asked to fill in a 2-day food
recall questionnaire. The questionnaires were subsequently
analyzed, by a trained dietician, with MetaDieta software
Vers.3.1, (Me.Te.Da, AP, Italy).
Statistical analysis
Analyses were carried out using STATA version 11 (StataCorp,
College Station, Texas, USA). Data are shown as mean and
Standard Error (SE), or median and interquartile range (IQR), as
appropriate. Normality of the distribution of the studied variables
was assessed by the Shapiro-Wilk test. Skewed variables were log
transformed before analysis.
The baseline characteristics of the two training groups were
compared by Student t-test or Fisher exact test, as appropriate.
Median attendance to exercise sessions between the two groups
was compared by Wilcoxon rank-sum test.
The area under the curve (AUC) of glucose levels was calculated
over the entire 48-h registration period and in selected periods of
the exercise and non-exercise days. Repeated measures ANOVA
was used to compare differences between the exercise and non-
exercise day in the two groups, with the AUCs (or the AUC
logarithms) as the dependent variables and time, study group, and
time-by-group interaction as independent variables. In this
analysis, particular attention was given to the interaction term as
its significance meant a different trend in the dependent variable in
the two groups; when this was true, separate Student t-test for
paired data were performed in both groups.
As LBGI and HBGI could not be normalized, non parametric
tests were used to compare the differences of these variables
between the exercise and non-exercise day (Wilcoxon matched-
pair test) and between groups (Wilcoxon rank-sum test). The
Bonferroni correction was applied in these analyses to adjust for
multiple comparisons.
Multiple regression analysis was carried out to assess whether
there were additional variables independently associated with
glucose changes. In this analysis gender, medication category
(insulin sensitizers vs secretagogues), age, and baseline glucose
levels were assessed as predictors of outcomes.
Tests with p,0.05 were considered statistically significant.
Results
Subjects of the aerobic and resistance training groups partic-
ipating in the sub-project had similar baseline characteristics
(Table 1). These features were also similar to those of the whole
cohort of subjects enrolled in the RAED 2 study (data not shown).
At the time the CGMS was implanted, after 10.960.4 weeks of
training, median attendance to supervised exercise sessions was
similar in the aerobic and resistance groups (93.5% vs 90.2%
respectively, p = 0.64).
Analysis of the 2-day food recall questionnaire, filled in by
participants during the CGMS registration period, showed that
calorie intake (15816191 vs 15046149 in the AER group, and
1468660 vs 14826194 kcal in the RES group, respectively in the
exercise and non-exercise days) was similar over the two days and
in both groups. Diet composition was also similar. In particular,
there were no differences in carbohydrate intake (196627 vs
194620 in the AER group, and 183613 vs 180636 g in the RES
group, respectively in the exercise and non-exercise days).
The glucose concentrations AUC over the entire 48-h CGMS
registration did not differ between groups [62536250 vs
63186457 (mg/dL) ? h, p= 0.90]. Mean glucose levels during
this time period were 12665 vs 13468 mg/dL, respectively in the
AER and RES groups (p = 0.37). Glucose readings at the
beginning of the exercise session were also similar in both groups
(11965 vs 13567 mg/dL, p= 0.45).
Table 2 shows the glucose concentration AUCs in the different
time periods assessed during both exercise and non-exercise days,
in the two groups. In both groups, the 24-h glucose AUC did not
differ between the exercise and non-exercise days, and there were
no differences, on both days, between the AER and RES groups.
However, comparison of the glucose AUC during the 60-min
exercise session and the corresponding 60-min period of the non-
exercise day showed the two groups had different behaviours
(time-by-group interaction p= 0.04, Tab.2). Subsequent analyses
of changes within groups showed significantly lower glucose AUC
during exercise than in the corresponding period of the non-
exercise day in the AER group, but not in the RES group (p= 0.04
and p= 0.90, respectively). Similar results were obtained when
analyses took into account a 5-min lag-time in glucose concentra-
tion changes between blood and interstitial fluid (data not shown).
Differences between the groups were also found in the
comparison of glucose AUC measured during the nocturnal
period following the training session and the corresponding period
of the non-exercise day (time-by-group interaction, p= 0.02,
Tab.2). Again, glucose concentration AUC was significantly lower
after the exercise session in the AER, but not in the RES group
(p = 0.03 and p= 0.62, respectively).
Fig. 3 shows the glucose levels behaviours in these periods, in
the two groups.
No subjects had severe hypoglycaemia or symptomatic hypo-
glycaemias. However, CGMS recorded several asymptomatic low
blood glucose readings. The LBGI, which is an index summarizing
in a single figure the extent and duration of hypoglycaemias, was
calculated for the nocturnal and for the 24-h periods of the two
days (Tab.2). In the AER group, LBGI was significantly higher in
the nocturnal period of the exercise day than in the corresponding
period of the non-exercise day (p= 0.012). Similar differences were
found when comparing the 24-h periods. However, this latter
difference did not reach statistical significance (p = 0.08). Con-
versely, the RES group did not show any differences in the
nocturnal or 24-h LBGI values between the two days (p = 0.88 and
p= 0.34, respectively).
The HBGI, which summarizes the extent and duration of high
blood glucose readings, was similar in the exercise and non-
exercise days in both groups (Tab.2).
Multiple regression analysis was carried out to assess whether
there were additional variables independently associated with
glucose changes. However, these showed that gender, medication
category (insulin sensitizers vs secretagogues), age and baseline
glucose levels were not significant predictors of changes in blood
glucose, either in the exercise period or in the nocturnal period or
in the whole exercise day (data not shown).
HbA1c changes from baseline were assessed in these subjects at
the end of the RAED2 protocol, after 4 months of intervention.
HbA1c levels showed similar mean improvements in the aerobic
and resistance groups (20.4860.14 vs 20.3960.16%, p= 0.70).
Discussion
In the present study we have compared the short-term effects on
blood glucose concentrations of a single bout of aerobic or
resistance exercise in type 2 diabetes subjects included in a regular
Acute Effects of Different Types of Exercise
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training programme. Glucose concentrations were measured by
CGMS for 48 hours, comprising a day with an exercise session
and the following non-exercise day. The exercise programmes
were of moderate intensity and designed according to current
recommendations for physical activity for these subjects [1]. Our
results showed that, although the aerobic and the resistance
training induced similar long-term improvements in HbA1c levels,
there were different behaviours between the groups in blood
glucose readings during and for several hours after a single exercise
session. In particular, there was a significant reduction of glucose
concentrations during the aerobic exercise but not during the
resistance exercise, and similar differences between groups were
also found in the nocturnal period following the training session.
Again, glucose concentrations were lower during the night
subsequent to an aerobic exercise session, whereas this phenom-
enon did not occur after resistance exercise.
Our findings are of speculative and practical interest. Previous
research showed that after a single bout of physical activity the
contraction-mediated increase in muscle glucose uptake persists
for several hours and the insulin mediated uptake for up to 48–
Table 1. Participants Baseline Characteristics.
Aerobic Group (N=13) Resistance Group (N=12) P value
Men/Women (n) 9/4 7/5 0.69
Age (years) 57.062.1 56.162.4 0.76
BMI (kg/m2) 29.561.2 31.661.2 0.22
Duration of Diabetes (years) 10.761.8 9.262.7 0.66
HbA1c (%) 7.360.2 7.560.2 0.54
Antidiabetic Therapy (n) 0.64
Diet alone 1 0
Metformin 7 7
Thiazolidinediones 2 0
Sulfonylureas 0 1
Meglitinides 0 1
Metformin and Sulfonylureas 3 2
Metformin and Meglitinides 0 1
VO2peak (mL?kg
21?min21) 25.560.9 24.861.6 0.71
Overall physical activity (MET min per week) 329663 255664 0.42
Caloric Intake (Kcal/day) 14686122 1373668 0.31
Values are mean6SE unless otherwise specified.
doi:10.1371/journal.pone.0049937.t001
Table 2. Glucose concentration AUCs, and LBGI and HBGI values during the exercise and non-exercise days in the Aerobic and
Resistance groups.
Aerobic group (N=13) Resistance group (N=12)
exercise non-exercise exercise non-exercise
P value
Time
P value Time-by-group
Interaction
Glucose AUCs (mg/dL)?h
Session day-time (6:30–7:30) 117 (104–125)a 131 (119–154) 133 (116–164) 140 (125–145) - 0.04
Nocturnal period (01:00–05:00) 363 (338–473)a 519 (367–595) 476 (393–525) 502 (454–540) - 0.02
24-h 2980 (2589–2509) 3073 (2754–3399) 3063 (2681–3314) 3203 (2826–3700) 0.45 0.34
LBGI
Nocturnal period (01:00–05:00) 1.27 (0–2.92)b 0 (0–1.55) 0.02 (0–1.64) 0 (0–1.93)
24-h 0.37 (0.07–1.45) 0.18 (0.03–0.77) 0.01 (0–0.96) 0.03 (0–0.99)
HBGI
24-h 2.12 (0.65–3.20) 1.52 (0.57–2.43) 1.68 (0.77–2.11) 1.60 (1.33–6.61)
Data are median and interquartile range.
P values refer to comparisons between groups by repeated measures ANOVA. Statistically significant figures are in bold type. When a significant time-by-group
interaction was found, differences within each group between the exercise and the corresponding non-exercise values were assessed by Student’s t test, and
statistically significant figures were indicated by symbols. Wilcoxon non parametric test was used to compare LBGI and HBGI values between the exercise and non-
exercise days (Wilcoxon matched-pair test) and between groups(Wilcoxon rank-sum test), and statistically significant figures were indicated by symbols.
ap,0.05 vs non-exercise;
bp,0.01 vs non-exercise.
doi:10.1371/journal.pone.0049937.t002
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72 h [1,7,15]. These observations suggested that the beneficial
effects of exercise on long-term glycaemic control can be ascribed
to the cumulative effects of the succeeding bouts of exercise. In our
study, the lack of significant differences in both groups between the
24-h glucose AUCs of the exercise and non-exercise days is
consistent with previous evidence of a prolonged metabolic effect
of either aerobic or resistance regular training. Furthermore, the
comparable 48-h glucose profiles between the two exercise groups
is consistent with an analogous long-term metabolic effect of
aerobic and resistance exercise, confirmed by the similar HbA1c
improvement observed in these subjects after 4 months of
intervention [4]. Nevertheless, the two groups showed significant
differences during and for several hours after exercise. In this
regard, the observed time course suggests that differences between
training types in the acute glucose changes are more likely due to
differences in the contraction-mediated pathway than in the
insulin mediated uptake. Accordingly, improvements of insulin
mediated glucose uptake were similar after 4 months of aerobic or
resistance training [4]. Differences between groups in the counter-
regulatory hormone response to exercise may also be hypothe-
sized. Interestingly, it was reported that exercise-induced GH
secretion could be greater after resistance exercise [16]. In our
study counterregulatory hormones were not assessed. Neverthe-
less, it seems unlikely that possible differences in secretion of these
hormones might account for the differences in blood glucose
between groups observed in the nocturnal period, 6–12 hours after
exercise.
From a practical point of view, the recent consensus statement
about exercise in type 2 diabetes, by the American College of
Sport Medicine (ACSM) and the American Diabetes Association
(ADA) [1], recommended combining aerobic and resistance
training in these subjects, in order to lower HbA1c levels [17]
and guarantee the specific benefits of both these exercise
modalities [18]. However, the lack of information about possible
differences in the acute effects of aerobic and resistance training on
glucose concentrations did not allow the ACSM/ADA experts to
suggest whether there should be any differences in medication
dosage and dietary carbohydrate adjustments to physical activity
in relation to the scheduled type of exercise. In this regard, it is
noteworthy that our experimental design explored the effects of
exercise sessions included in a training programme, to assess
whether each single exercise bout causes acute changes of blood
glucose over the chronic effects of a long-term training. In terms of
clinical practice, this may be even more interesting than
comparing an exercise day with a true non-exercise day, which
is a somewhat artificial model.
Interestingly, in our study the LBGI index, which summarizes
the severity and duration of hypoglycaemic episodes and is a
Figure 3. Mean glucose concentrations behavior during selected periods, in the aerobic (A) and the resistance (B) groups. Upper
panels: glucose concentrations during the 60-min exercise session and the corresponding period of the non-exercise day. Lower panels: glucose
concentrations during the nocturnal sleeping period (01:00–05:00 am) of the two days. White circles indicate glucose values in the exercise day, and
black circles those in the non-exercise day. P values refer to differences in glucose concentration AUCs between the exercise day and the non-exercise
day.
doi:10.1371/journal.pone.0049937.g003
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reliable predictor of severe hypoglycaemia risk [14], increased
significantly during the night following aerobic exercise, whereas it
did not change after resistance exercise. It should be underlined
that the risk of hypoglycaemia, as estimated by the LBGI index,
was low in these diabetic patients and mildly increased after the
aerobic exercise session. Nevertheless, most subjects in our study
were given metformin alone, which carries a very low risk of
hypoglycaemia and might even blunt the post-exercise blood
glucose reduction [19], whereas a small number of them were
given insulin secretagogues, i.e. received medications which
substantially increase hypoglycaemia risk. Therefore, these differ-
ences in the LBGI index observed during the night after exercise,
even if small, merit attention.
Some previous studies assessed the acute effects of exercise on
blood glucose in type 2 diabetic subjects not involved in structured
training programmes, reporting that physical activity lowered the
time spent in hyperglycaemia, as compared to a non-exercise day
[20–21]. However, to the best of our knowledge, only one recent
study has compared, using a CGMS, the acute effects on blood
glucose of a single session of aerobic or resistance exercise in these
patients. Van Dijk et al [22] reported, in a crossover study, similar
reductions in the prevalence of hyperglycaemia over a 24-h period
after aerobic or resistance exercise, as compared to a non-exercise
day. Moreover, in this study, a greater time spent in hypoglycae-
mia was reported in the evening after exercise, and this figure was
somewhat higher after aerobic activity, although the study did not
provide analysis of differences between the exercise types in this
time frame. In our study the exercise session was undertaken in the
late afternoon, when many subjects could train more easily, after
work or family activities. In contrast, in the van Dijk study,
exercise was carried out in the late morning. This difference may
likely explain why in our study hypoglycaemia risk was higher in
the nocturnal period, whereas in the van Dijk study this
phenomenon occurred earlier, in the evening.
Interestingly, all recorded hypoglycaemias were asymptomatic
in our subjects. It is worth noting that in subjects with long-
standing type 2 diabetes, the hypoglycaemia rate is substantially
higher than commonly thought, as most episodes remain
undiagnosed [23], and that hypoglycaemias are considered the
most likely candidate responsible for the lack of beneficial effects or
even the increased risk of mortality observed during intensive
glucose-lowering therapy [24–25].
Unlike the findings of previous studies, in our subjects the 24-h
blood glucose AUC and the 24-h HBGI value, which summarizes
duration and extent of hyperglycaemia, were unaffected by either
aerobic or resistance exercise. Differences in the experimental
design probably explain these different results. In particular, we
assessed what effects a single bout of exercise has over the
sustained effects of training, whereas the other studies compared
exercise with a non-exercise condition.
Interestingly, findings consistent with our data were reported in
a preliminary study [26] carried out in trained individuals with
type 1 diabetes submitted to continuous glucose monitoring during
and after aerobic or resistance exercise. Aerobic exercise caused
greater reduction of blood glucose and a greater need for
carbohydrate supplementation during aerobic exercise than
resistance exercise. More recently, the same authors have
examined in these patients the effects of combined exercise
sessions, in which the aerobic training was performed either before
or after the resistance training [27]. In this study, blood glucose
reduction was again greater during aerobic exercise than
resistance exercise, especially when the aerobic component came
first. Moreover, there was a tendency to differences in AUC for
post-exercise nocturnal hypoglycaemia according to the sequence
in aerobic and resistance exercise, the glucose reduction being
greater when aerobic exercise preceded resistance exercise.
As a whole, these data indicate that a better understanding of
the acute effects of each specific type of exercise is needed, in order
to maintain glucose levels in an appropriate range during and after
physical activity. This is also relevant if we consider that
therapeutic adjustments induced by fear of exercise-induced
hypoglycaemia often cause a suboptimal metabolic control during
physical activity in diabetic patients, mitigating the potential
beneficial effects of exercise.
The strengths of our study are the careful experimental design
and the assessment of the effects of bouts of exercise included in a
regular training programme, in order to reproduce real-life
conditions. To the best of our knowledge, our study is the first
to assess the acute effects of exercise within a long-term training
programme in type 2 diabetic subjects.
A limitation is the somewhat small sample size, although it did
not prevent us from finding several statistically significant
differences. Moreover, owing to the inclusion/exclusion criteria,
extrapolation of the present findings to other classes of diabetic
patients, such as those on insulin therapy, should be undertaken
with caution.
In conclusion, although aerobic and resistance training have
similar long-term metabolic effects in type 2 diabetes subjects, the
acute effects of single bouts of these exercise types differ. In
particular, aerobic exercise lowers blood glucose concentrations to
a greater extent than resistance exercise, both during and up to
twelve hours after the exercise session, carrying a higher risk of
exercise-induced hypoglycaemia. Of particular concern is late-
onset hypoglycaemia, especially when the exercise is scheduled in
the late afternoon, as this risk occurs in the sleeping nocturnal
period. These findings suggest that adjustments of medications
and/or carbohydrate intake in diabetic subjects should also take
into account the scheduled type of exercise. Further research is
needed to establish the mechanisms underlying differences in the
short-term effects of aerobic and resistance training, and to assess
the acute metabolic changes induced by a combination, in the
same session, of aerobic and resistance exercise.
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